Department of Surgery, Stavanger University Hospital, POB 8100, 4068 Stavanger, Norway.
World J Surg. 2009 Dec;33(12):2695-703. doi: 10.1007/s00268-009-0255-4.
At least 12 harvested lymph nodes are recommended for proper staging of colon cancer. The effect of tumor-related factors associated with lymph node harvest is not well understood as data are lacking. We investigated tumor-related factors in relation to the number of lymph nodes harvested.
Patient and tumor characteristics were investigated in relation to harvested lymph nodes (LN >or= 12), number of metastatic nodes, LN ratio (LNR), and prognosis with univariate and multivariate analyses.
An LN harvest >or=12 nodes was achieved in 36% of the patients. Having <12 nodes harvested was not associated with increased risk for locoregional recurrence, distant metastasis, or decreased survival. Tumor size >5 cm, microsatellite instability (MSI), and proximal tumor location predicted a harvest of LN >or= 12. The highest rate (54%) of LN >or= 12 was found for MSI cancers [odds ratio (OR) 2.9, 95% confidence interval (CI) 1.3-6.5; P = 0.011]. Multivariate analysis identified a proximal location as an independent factor of LN >or= 12 (adjusted OR 3.5, 95% CI 1.5-8.2; P = 0.003), with MSI an independent factor in stage II to III colon cancer (adjusted OR 2.6, 95% CI 1.1-6.0; P = 0.026). To determine the best prognosticator, LNR was the only significant factor in the multivariate analysis (Cox proportional hazards) with a hazard ratio (HR) of 2.9 (95% CI 1.1-7.8; P = 0.038) for LNR 0.01-0.17 and an HR of 5.8 (95% CI 2.5-13.1; P < 0.001).
Proximal tumor location and microsatellite instability are associated with a higher number of lymph nodes harvested, pointing to possible underlying genetic and immunologic mechanisms. The LNR is an independent prognostic variable for colon cancer.
至少 12 个已采集的淋巴结被推荐用于结肠癌的适当分期。由于缺乏数据,与淋巴结采集相关的肿瘤相关因素的影响尚不清楚。我们调查了与淋巴结采集数量相关的肿瘤相关因素。
通过单因素和多因素分析,研究了与患者和肿瘤特征相关的已采集淋巴结数量(LN>or=12)、转移性淋巴结数量、淋巴结比(LNR)和预后。
36%的患者采集了 LN>or=12 个淋巴结。采集的淋巴结数量<12 个与局部复发、远处转移或生存率降低无关。肿瘤直径>5cm、微卫星不稳定性(MSI)和肿瘤近端位置预测 LN>or=12 个淋巴结的采集。MSI 癌症的 LN>or=12 率最高(54%)[比值比(OR)2.9,95%置信区间(CI)1.3-6.5;P=0.011]。多因素分析确定肿瘤近端位置是 LN>or=12 的独立因素(调整 OR 3.5,95%CI 1.5-8.2;P=0.003),MSI 是 II 期至 III 期结肠癌的独立因素(调整 OR 2.6,95%CI 1.1-6.0;P=0.026)。为了确定最佳预后因素,LNR 是多因素分析(Cox 比例风险)中的唯一显著因素,LNR 为 0.01-0.17 的风险比(HR)为 2.9(95%CI 1.1-7.8;P=0.038),LNR 为 0.01-0.17 的 HR 为 5.8(95%CI 2.5-13.1;P<0.001)。
肿瘤近端位置和微卫星不稳定性与采集的淋巴结数量较多有关,这可能与潜在的遗传和免疫机制有关。LNR 是结肠癌的独立预后变量。